These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 29656584)

  • 1. Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
    De Paepe KN; De Keyzer F; Wolter P; Bechter O; Dierickx D; Janssens A; Verhoef G; Oyen R; Vandecaveye V
    J Magn Reson Imaging; 2018 Oct; 48(4):897-906. PubMed ID: 29656584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
    Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
    Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging.
    Giraudo C; Karanikas G; Weber M; Raderer M; Jaeger U; Simonitsch-Klupp I; Mayerhoefer ME
    J Magn Reson Imaging; 2018 May; 47(5):1217-1226. PubMed ID: 29086453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
    Schaarschmidt BM; Buchbender C; Nensa F; Grueneisen J; Gomez B; Köhler J; Reis H; Ruhlmann V; Umutlu L; Heusch P
    PLoS One; 2015; 10(1):e0116277. PubMed ID: 25574968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of whole body diffusion weighted MR imaging for diagnosis and staging of malignant lymphoma.
    Li S; Xue HD; Li J; Sun F; Jiang B; Liu D; Sun HY; Jin ZY
    Chin Med Sci J; 2008 Sep; 23(3):138-44. PubMed ID: 18853847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps.
    Yin JD; Song LR; Lu HC; Zheng X
    World J Gastroenterol; 2020 May; 26(17):2082-2096. PubMed ID: 32536776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
    Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
    Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
    Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Body Diffusion-Weighted MRI Compared to
    Shapira-Zaltsberg G; Wilson N; Trejo Perez E; Abbott L; Dinning S; Kapoor C; Davila J; Smith B; Miller E
    Can Assoc Radiol J; 2020 May; 71(2):217-225. PubMed ID: 32062992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC).
    Freihat O; Pinter T; Kedves A; Sipos D; Cselik Z; Repa I; Kovács Á
    Cancer Imaging; 2020 Aug; 20(1):56. PubMed ID: 32771060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
    Xu L; Tian J; Liu Y; Li C
    J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
    Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
    J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).
    Bernstine H; Domachevsky L; Nidam M; Goldberg N; Abadi-Korek I; Shpilberg O; Groshar D
    Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
    Gu J; Chan T; Zhang J; Leung AY; Kwong YL; Khong PL
    AJR Am J Roentgenol; 2011 Sep; 197(3):W384-91. PubMed ID: 21862763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between malignant and benign thyroid nodules and stratification of papillary thyroid cancer with aggressive histological features: Whole-lesion diffusion-weighted imaging histogram analysis.
    Hao Y; Pan C; Chen W; Li T; Zhu W; Qi J
    J Magn Reson Imaging; 2016 Dec; 44(6):1546-1555. PubMed ID: 27093648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort.
    Donners R; Yiin RSZ; Blackledge M; Koh DM
    Cancer Imaging; 2021 Nov; 21(1):64. PubMed ID: 34838136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
    Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
    Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.
    Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Simonitsch-Klupp I; Raderer M; Mayerhoefer ME
    Acad Radiol; 2018 Apr; 25(4):453-460. PubMed ID: 29199055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.